Search Results
You searched for "Merck" ( 314 results )
-
Korea’s CMO ramp-up lures biotech investors
South Korea’s growing biopharmaceutical production capacity is increasingly making the country an attractive investment destination for global life science companies, industry sources said Thursday. Since 2016, global pharmaceutical and biotech firms started building their research and development centers and production facilities in Korea, especially within the Songdo Bio Cluster in Incheon, where the biopharmaceutical production capacity has reached 1.2 million liters, the world’s
Industry March 28, 2024
-
Merck to invest 300m euros in new bioprocessing center in Korea
German pharmaceutical group Merck Life Science said Thursday the company will invest around 300 million euros ($326 million) to build a new bioprocessing complex in South Korea, its largest investment yet in the Asia-Pacific region. The new investment comes as the company renews its commitment to expanding its production capacities for biotech products in the fast-growing market. It also aims to boost the overall biotech industry in the region, saying the new facility alone will create some 300
Industry March 21, 2024
-
Merck’s Keytruda tops drug sales in Korea
Merck’s immuno-oncology drug Keytruda, one of the best-selling drugs in the world, topped drug sales in Korea for the second consecutive year in 2023, according to market tracker IQVIA on Tuesday. Keytruda’s sales in Korea came to some 399 billion won ($300 million) in 2023, up 159 billion won from the previous year, while global sales of Keytruda hit $25 billion, making it the top-selling drug worldwide. “Keytruda’s success in the country came as the drug can be prescrib
Industry Feb. 27, 2024
-
Brinc Launches Brinc Academy: A Comprehensive Self-Guided Online Course to Empower Founders on Their Startup Journey
HONG KONG, Feb. 9, 2024 /PRNewswire/ -- Brinc, a leading global venture accelerator, is excited to announce the launch of Brinc Academy, an innovative self-guided online course designed to support budding founders and entrepreneurs as they embark on their startup journey. Brinc Academy offers a roadmap to launching and scaling startups with precision and insight, covering essential topics such as defining business ideas, attracting customers, creating attention-grabbing pitch decks, and fundrais
PR Newswire Feb. 9, 2024
-
Merck to pour capital into Korea's AI chip industry
Merck, the science and technology juggernaut based in Germany, will continue to put capital into Korea in line with the growth of the country's semiconductors industry while expanding cooperation with key clients and the world's two largest memory chip producers, Samsung Electronics and SK hynix. The German firm is seeking to leverage its capabilities to supply materials and equipment needed for chip manufacturing as its Korean clients increase their investments into artificial intelli
Technology Feb. 2, 2024
-
Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI
Results showed partial response being confirmed in 7 out of 42 patients Partial response was observed in 3 out of 8 patients who were previously treated by immunotherapy SEOUL, South Korea, Jan. 24, 2024 /PRNewswire/ -- Genome & Company (KOSDAQ: 314130), a clinical stage biotech leading in microbiome therapeutic development announced on January 18th (local time) that a poster was presented on the positive topline results from the phase 2 clinical trial (NCT05419362) in gastric
PR Newswire Jan. 25, 2024
-
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors
Initiation of Phase 1a/b clinical trial exploring MTD, RP2D, safety and tolerability of PMC-309 monotherapy and combination therapy with KEYTRUDA® The clinical trial aims to enroll a total of 67 patients across four institutions in Australia DAEJEON, South Korea, Jan. 24, 2024 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on next-generation antibody therapeutics, announced today the initiation of patient dosing in the Phase 1a/b clin
PR Newswire Jan. 24, 2024
-
Merck Korea launches infertility support program for employees
German chemicals giant Merck has launched a fertility benefit program for all employees working at its Korean unit to help address the nation’s severely low birth rate, the company said Monday. Earlier this month, the Korean unit became the tenth to join the program, established in October of last year and designed to to help Merck employees having difficulties in conceiving a pregnancy. The scheme was first applied in eight countries, including Germany, the UK, Switzerland, China and Taiw
Industry Jan. 22, 2024
-
[CES 2024] Merck to unveil vision for 'material intelligence' at CES
Merck, a German-based science and technology company, will present its contributions to advancing the electronics industry through "material intelligence" at CES 2024, the company said Monday. “We are pushing the boundaries of science and technology to make future trends possible. Together with our customers, we enable artificial intelligence,” said Kai Beckmann, a member of Merck's executive board and CEO of the electronics division. “Our customers use our mater
Industry Jan. 8, 2024
-
Rx-360® Announces 2024 Board of Directors
PHILADELPHIA, Dec. 27, 2023 /PRNewswire/ -- Rx-360® is pleased to announce its 2024 Board of Directors. As a non-profit, the Board of Directors is positioned to continue driving the Rx-360® mission of pharmaceutical supply chain security, material quality, and patient safety. This announcement follows the organization's successful growth in 2023. The Rx-360® 2023 Board of Directors includes: Scott Kammer (Chair): Takeda Rob Welsh (Chair Emeritus): Avantor
PR Newswire Dec. 27, 2023
-
The MarTech Summit Asia @Singapore is taking place on 23 & 24 April 2024
Grand Gathering of MarTech Professionals across Asia SINGAPORE, Dec. 21, 2023 /PRNewswire/ -- The MarTech Summit Asia is taking place on 23 & 24 April 2024 at The Stamford Ballroom, Raffles City Convention Centre, Singapore. As the fourth year in Singapore, The MarTech Summit series expands our scale to the whole Asia region. For the ever-evolving marketing & technology world, this summit is themed MarTech Revitalisation: Assemble, Synergise, Impact, Advance. We will gather 3
PR Newswire Dec. 22, 2023
-
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately. Piers Ingram, Ph.D., Chief Executive Officer and co-founder of Hummingbird Bioscience said: "We are delighted that Angèle is joining our team. Her de
PR Newswire Dec. 11, 2023
-
Merck Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner
Bayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership to enable the self-driving labs of tomorrow DARMSTADT, Germany, Dec. 6, 2023 /PRNewswire/ -- Merck, a leading science and technology company, and the Acceleration Consortium, based at the University of Toronto, Canada, today jointly announced that their AI-driven experimentation planner Bayesian Back End (BayBE) is now available open-source on GitHub, w
PR Newswire Dec. 7, 2023
-
Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis
Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies Virtually screens compounds from a universe of >60 billion chemical targets and evaluates synthesis routes for safer, cost-effective, higher-yield drug manufacturing Recommends chemicals, reagents and building blocks for synthesis DARMSTADT, Germany, Dec. 5, 2023 /PRNewswire/ -- Merck, a leading science and technology company, today launched its AIDDISON™
PR Newswire Dec. 6, 2023
-
More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds
Global research from the International Diabetes Federation reveals that 72% of people living with diabetes only received their diagnosis because they had at least one of the related complications – such as loss of vision, nerve damage or heart disease. BRUSSELS, Nov. 14, 2023 /PRNewswire/ -- Seven in ten people living with diabetes (72%) only found out they had diabetes after developing complications associated with the condition. Additionally, almost all (94%) of those surveyed had experience
PR Newswire Nov. 14, 2023
-
Brinc Hosts Successful Asia Health Innovation Summit 2023, Fostering Greater Ideations and Collaborations in the Healthcare Sector
HONG KONG, Nov. 10, 2023 /PRNewswire/ -- The Asia Health Innovation Summit 2023, hosted by global venture accelerator Brinc as part of the StartmeupHK Festival curated by InvestHK, attracted an online audience of over 1,000 and a full capacity of more than 200 in-person attendees at The Park Lane Hong Kong-A Pullman Hotel yesterday. The third-annual event solidified its position as a premier gathering for industry leaders, entrepreneurs, investors, and professionals in Asia's health innovation s
PR Newswire Nov. 10, 2023
-
[Herald Interview] Merck seeks growth with Korean chipmakers
The global semiconductor industry is struggling to make ends meet amid sluggish demand and price decreases, but German technology firm Merck sees Korea, the home of the world's two largest memory chip producers Samsung Electronics and SK hynix, still an attractive destination for business. “The leading players in the industry that are investing the most amount in new capacity, our Korean customers are at the top of that list. Making sure that we are continuing to engage with the leadi
Technology Nov. 2, 2023
-
Brinc and Hatcher+ Team Up to Supercharge Climate Tech Startups
HONG KONG, Oct. 30, 2023 /PRNewswire/ -- Brinc, a leading global venture accelerator, and Hatcher+, an award-winning, data-driven VC, have announced their intention to identify, invest in, and support the growth of 300 new climate tech startups driving innovation over the next three years. Brinc and Hatcher+ Team Up to Supercharge Climate Tech Startups The partners will leverage Brinc's global venture accelerator network to find new entrepreneurs, and Hatcher+'s AI-powered FAAST p
PR Newswire Oct. 30, 2023
-
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy
- Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembrolizumab treatment response SEOUL, South Korea, Oct. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a research collaboration with The University of Texas MD Anderson Cancer Center to analyze the use of Merck's (known as MSD outside the US and Canada) Keytruda (pemb
PR Newswire Oct. 28, 2023
-
Merck shares digital solutions for chip industry
Merck Korea, the Korean unit of the German chemicals giant, shared the company’s solutions for the future semiconductor industry at an academic conference held by Alumninetzwerk Deutschland-Korea, Tuesday. Under the topic “Unlocking the potential of artificial intelligence and machine learning in semiconductor manufacturing,” Steven Eulig, head of business development for digital solutions at Merck Electronics, delivered a speech on the company’s digital insight. While th
Industry Sept. 20, 2023
Most Popular
-
1
Hyundai Motor eyes 80,000 jobs, W68tr investment at home by 2026
-
2
Korea enters full election mode
-
3
Seoul bus drivers go on general strike, cause morning rush hour delays
-
4
Immigrant woman stabbed to death by Korean husband
-
5
Official campaigning kicks off for April 10 elections
-
6
Dialogue hopes fade as doctors pick hard-liner as new head
-
7
Coupang pledges W3tr to expand Rocket Delivery nationwide by 2027
-
8
[Election Battlefield] Political novice to face off star politician in ‘swing district’
-
9
Court upholds jail term for man who attempted to murder ex-girlfriend
-
10
[Herald Interview] Son Suk-ku chooses to be swayed by others in navigating life